Cancer-free for nearly 20 years, RIT graduate student Bryona Hamilton seeks to educate patients, survivors, and family ...

New research suggests exercise during chemotherapy may help protect cognitive function, offering hope for patients struggling ...

Patients with stage IA HER2+ breast cancer and smaller tumors had high BCSS rates whether they received adjuvant chemotherapy or not.

Pelareorep plus chemotherapy with or without Tecentriq had an acceptable safety profile in patients with newly diagnosed ...

The pooled prevalence of chronic painful neuropathy is 41.22% among individuals with chemotherapy-induced peripheral neuropathy (CIPN).

One patient with TNBC describes the challenges she faced trying to de-escalate a grueling treatment regimen despite warnings ...

A non-profit partnered with Boardman Junior High School to help those fighting cancer. It’s called a “Blessed Bag,” and it ...

Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...

Combination treatment with ibrilatazar and chemotherapy has demonstrated “promising efficacy and safety” in patients with advanced squamous non-small cell lung cancer (NSCLC), according to researchers ...

Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's ...

Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...

Patient safety and well-being is behind Rosemere Cancer Foundation’s New Year re-reprint of chemotherapy alert cards.